My new blog is now online! David G. Henry and I have created the Waco Patent Blog to provide news and information regarding patent litigation the exciting Western District of Texas, Waco Division! Join us as we explore this exciting patent venue! Don't worry, though: I will still be managing this China Patent Blog as I split my time between China and Texas!
#dbllawyers #albright #wdtx #patentlitigation #waco #wacopatents #patents
My firm, Dunlap Bennett & Ludwig won a significant victory in a high-profile patent lawsuit.
A Texas U.S. District Judge doubled a jury award to $24.5 million and added $4.75 million in attorneys’ fees and expenses for a toy company that won a case against Telebrands Corporation. In doing so, the judge found that Telebrands infringed two patents on a water balloon device. The judge also found that Telebrands’ intentionally copied the patented product and used obstructionist tactics throughout the case. The product “Bunch O Balloons” is produced by toy manufacturer ZURU pursuant to a license with Tinnus. Telebrands copied the product and released an “As Seen on TV” infomercial-style ad campaign calling its product “Balloon Bonanza."
In 2015, Tinnus and ZURU sued Telebrands, claiming that Telebrands’ product infringed their patent. Judge Robert W. Schroeder III issued a 64-page opinion in which he added to the plaintiffs’ trial victory by doubling the jury award to $24.5 million. He also awarded plaintiffs $4.75 million in attorney fees and expenses and denied Telebrands’ motions for a new trial.
The opinion is available here.
For more information, see the DBL website summary or the IP Law360 story.
UPDATE: For those having problems accessing the podcast, it is available directly from this blog at this link.
My firm recently launched a new podcast, Blackletter Podcast. On the most recent podcast, Tom Dunlap interviewed my partner, Dragon Wang, and me regarding protecting and defending intellectual property in China.
Here is a link to the podcast on iTunes: Tom Dunlap speaks with Erick Robinson and Dragon Wang, attorneys for Dunlap Bennett & Ludwig, about how to protect and defend intellectual property in China.
On 4 January 2019, the National People’s Congress published a draft amendment to the Patent Law (the “Amendment”). See the Chinese version here. The Amendment is open for public comments through February 3, 2019 via the NPC website.
China Law & Practice (ALM) published my article analyzing the provisions of the Amendment here. Unfortunately, it is behind a paywall. However, here is a redline of the changes in English.
Email me if you have any questions or if I or my firm, Dunlap, Bennett & Ludwig can assist you regarding Chinese IP!
I wanted to expand here on the article I recently published at CGTN. In that article, I pointed out that as of January 1, 2019, the Supreme People’s Court (“SPC”) enacted a national appellate court for civil and administrative IP cases. However, it is important to note that the new Intellectual Property Rights Court for Appeals (“IPRCA”) is not just an appellate court, as it can also serve as a trial court.
In addition to hearing appeals in cases concerning invention patents, utility model patents, design patents, new plant varieties, layout design of integrated circuits, know-how, computer programs, and antitrust, the new IPRCA can also hear “major” and “complicated” first instance civil and administrative cases, as well as other cases that the SPC considers should be tried before the IPRCA. Exactly what the SPC considers “major” and “complicated” is not clear. Further, there is a catch-all category including “[o]ther cases that the SPC considers should be tried before the IP Court.”
Until the new court has some cases under its belt and/or the SPC provides additional interpretations, on Dec. 28, 2018, the SPC issued the Provisions on Issues Concerning IP Tribunal (the “Provisions”) providing details regarding the IPRCA. See here for the Chinese version of the Provisions or here for a (quite imperfect) Google-translated English version. UPDATE: here is bilingual version.
Article 2 of the Provisions states that the IPRCA shall have jurisdiction over the following:
Other than jurisdictional issues, the Provisions also provide some additional details. For example, Article 4 provides for electronic service and disclosure (hallelujah!). Article 5 allows for electronic and online evidence exchanges, pre-trial meetings, and other court functions to maximize efficiency (again, wonderful!). Article 6 states that the IP Court may, if needed, travel to the location of the original trial or case. Article 8 states that case filing information may be inquired through the electronic litigation platform and the China Trial Process Information Open Network. Although this seems to anticipate a structure not in existence yet, it is certainly cause for excitement because one of the most limiting features of Chinese litigation is the lack of a full electronic case management system.
I will continue to provide updates as we learn more about the new IP Court. For now, I am a huge fan and see this as a real game-changer. I look forward to finding out for what cases the new court will act as a trial court, and what resources will be available to ensure that the new organizational structure does not create a paralyzing bottleneck in an already-overloaded system.
See my latest article on China’s new IP Appellate Court published by the China Global Television Network, the English-language news channel of the State-owned China Global Television Network group:
This will be a short post, as I just wanted to point out that the Supreme People’s Court very recently granted InterDigital’s petition for a retrial in a case involving royalties to be paid by Huawei. The high court’s ruling overturns a decision by the Guangdong Province High Court decision that certain InterDigital Chinese patents should not exceed 0.019 percent of the actual sales price of each Huawei product.
I will try to get the raw data shortly, but the English-language report saying this is here: https://news.bloomberglaw.com/ip-law/interdigital-granted-huawei-patent-case-retrial-by-china-spc
This is a big deal, as it will make it nearly impossible for Chinese and other companies to cite IDC v. Huawei for the purpose of supporting a 0.02% royalty rate. Indeed, Chinese damages law is quickly evolving to catch up with the rest of the progressive patent law and procedure we continue to see coming out of China. This is great news for innovation, for China, and for the innovators worldwide.
Bilingual (English-Chinese) Version of Apple Injunction Order in Both Qualcomm Cases from Fuzhou Intermediate People's Court
Because not everyone can read Chinese, here are downloadable PDF copies of the bilingual versions of both orders from the Fuzhou court regarding the injunction against Apple requested by Qualcomm:
Note that in China, each patent requires a different "case." Here, because there are two patents, there are two separate orders: one for Patent No. ZL201310491586.1 and one for ZL200480042119.X. I encourage you to read both orders, although they are largely the same.
Interesting facts from these documents:
I have officially joined the U.S. law firm of Dunlap, Bennett & Ludwig (DBL) as a Partner. DBL is a leading full-practice law firm with offices in 17 cities in the United States, China, Europe, Canada, and Puerto Rico. I will also be working with IntellStrategy, a Chinese patent agency. IntellStrategy is closely affiliated with, but separate from, DBL. The DBL-IntellStrategy alliance allows our team in North America, Europe, and China to achieve goals for our clients that other law firms, patent agencies, and consultancies cannot. For example, unlike many international firms which "cannot assist clients with Chinese IP law," IntellStrategy can directly represent Chinese and international clients in China's courts and before the Chinese patent office and Patent Reexamination Board.
I will continue to split my time between Beijing and Houston. One of the biggest advantages is that I can represent clients in both the U.S. and China now! I am still technically a consultant in China because I am not Chinese and cannot be admitted to the Chinese bar (but thanks to IntellStrategy, my colleagues can!). However, I will continue to manage all types of IP issues in China, focusing on patent licensing and litigation.
Further, I can use my Texas and New York bar cards again! I love my Chinese practice, but I miss arguing in court, taking deposition, and even (gulp!) managing discovery! Also, because DBL has an office in Europe, I can help companies enforce their patents simultaneously in the most important patent courts in the world.
Joining me in my move will be my entire Chinese team, including patent litigation superstar, Dragon Wang.
In case you are wondering, my short stint at my prior firm did not work out for reasons mostly related to conflicts. It is what it is, and I am very excited to work with my new colleagues!
The Fuzhou Intermediate People’s Court in China has granted Qualcomm's request for two preliminary injunctions against four Chinese subsidiaries of Apple Inc. The affected Apple products are the iPhone 6S, iPhone 6S Plus, iPhone 7, iPhone 7 Plus, iPhone 8, iPhone 8 Plus and iPhone X.
The patents at issue enable users to adjust and reformat the size and appearance of photographs, and to manage applications using a touch screen when viewing, navigating and dismissing applications on their phones.
I have not seen the order, but Apple is saying that the injunction only includes older versions of iOS. This is a developing issue and I will provide information as I receive it. What is clear, though, is that because this is a preliminary injunction, the injunction should NOT be stayed pending appeal. Also, there may be some political issues at play because whereas Qualcomm has paid its dues in China, Apple has never been a friend of China. One need only consider that Qualcomm is a supplier to some of the most important companies in China, whereas Apple is a competitor to those same companies.
FYI: Here is a good article on some of the details as they are known to Reuters.
Stay tuned - this one is big and could get bigger. I need to go now because I have to go file a bunch of cases in Fuzhou!
A very interesting article was recently published in China on why NPEs are good for China. It focuses on iPEL, an NPE that has over 1000 Chinese patent families. The article was published by IP House, a Chinese publisher that has a contract with the Chinese government and courts to publish the most database of IP-related court decisions in China. For a PDF of the article in Chinese and English, click here.
I have been asked for copies of various of my publications and presentations over the last few weeks, and have struggled with a way to make them available. Until I figure out a better way, here they are, with clickable links:
The good news is that China’s entire civil litigation system has significantly improved, not just its patent enforcement system. Contracts are fairly and effectively enforced between foreign and Chinese parties. This means that if the contract is breached, a foreign company can get monetary damages and/or injunctive relief from a Chinese court so long as a foreign company: (1) executes a valid contract with a Chinese company, (2) that contract is sufficiently straightforward that a Chinese court can make a ruling of fact without significant investigation, and (3) the contract is not subject to China’s Technology Import Export Regulation (“TIER”), or the foreign company builds in a business advantage to incentivize the Chinese company not to escape the contract via TIER.
This post addresses TIER and some ways to possibly deal with it, best practices for forming JVs with Chinese companies, and how to protect core and non-core IP in China.
II. China’s Technology Import Export Regulation (TIER)
A. TIER Restrictions
Licensing is the primary means by which technology flows into markets and it may also set the stage for joint additional advances. The challenge to parties negotiating a licensing agreement is to find terms that are mutually beneficial, so that agreement is in the interest of both sides. Especially in the context of high technology, and associated intellectual property, it is critical that the parties have great flexibility in arriving at mutually beneficial terms as the market and circumstances demand.
Unfortunately, TIER imposes rigidities as they relate to certain key terms, making it more difficult for the parties to reach agreement. The Chinese government, via the Ministry of Commerce (MofCOM) has mandated certain conditions be a part of any license of technology into China, regardless of whether those terms are in the parties’ contract, or even if these terms are specifically contradicted by contract. TIER mandates that foreign licensors fully indemnify Chinese licensees, surrender ownership to any improvements, and not prohibit marketing rights of Chinese licensees.
The first potential problem with TIER pertains to indemnity terms, which govern which party should bear the burden if the licensee’s right to the licensed technology is challenged by a third party. Given the wide variety of circumstances, there is no single best approach to indemnity terms, which should be left to the parties to address in a mutually beneficial manner. TIER, however, inflexibly imposes all indemnity risks on the foreign licensor.
Interestingly, many open source licenses are incompatible with TIER because they mandate that no indemnity is provided. For example, most open source licenses do not provide any warranties of non-infringement or any provisions for indemnification and some licenses specifically disclaim any warranty or indemnification. This obviously contradicts TIER and requires a violation of either the open source license or TIER. As use of open source-licensed code grows in China, this will be an important issue. Although TIER does not have a strong record of enforcement, open source licenses do. Indeed, the penalties for violation of such license terms can be draconian, including enjoining distribution and use of the software, as well as damages and attorneys fees.
The second potential problem with TIER pertains to rights in technology improvements developed by the licensee. A licensor will often desire to have shared rights in improvements, in exchange for giving the licensee more favorable terms, such as by lowering any royalty payment. A licensor unable to share in improvements developed by the licensee risks being locked out by the new development, and so it may conclude that it cannot reach a deal with a Chinese partner due to the great uncertainty created by TIER. Absent the flexibility to negotiate shared access to improvements, a technology licensor may choose to avoid China completely, or to deal with an affiliated company that it can trust. Again, many open source licenses require any derivative works, including improvements, to be freely available to the public, so that the parties must violate either the open source license or TIER.
The third concern pertains to licensing parties’ allocation of marketing rights. The business-driven bargaining in a licensing transaction often involves allocating market rights between a licensor and a licensee. For example, a given technology transaction may give a Chinese company the exclusive marketing rights in China and a U.S. company the exclusive marketing rights in North America. However, TIER prohibits licensing agreements that “unreasonably restrict[s] the export channels” of the licensee. Under this TIER provision the licensing parties cannot freely negotiate allocation of market rights according to their business needs and proposed level of license fees. Absent the flexibility to allocate marketing rights, a foreign licensor and a Chinese licensee may have to forgo their licensing partnership despite interest by both.
B. Ways of Managing TIER Restrictions
There are very few cases in China in which TIER has been asserted by China or Chinese companies to void specific provisions of a contract. Although this is good news, it is still not all that comforting to foreign businesses forced to accept uncertainty in licensing technology into China. There are a few ways of managing the potential dangers of TIER.
First, it is clear that if a Chinese company voids important contract provisions using TIER, then that company will have significant problems ever working with a foreign company again. Foreign licensors, and foreign partners in general, will no longer trust such a Chinese entity to abide by its word. Such a consequence would be, therefore, bad for the Chinese entity as well as the foreign entity. Presumably, a Chinese company would only void the contract provisions via TIER in an instance where the value of doing so is very high – higher than the loss of future ability to work with foreign companies. Therefore, it may be possible to avoid such a case by providing business incentives (such as additional revenue, equity, or geographic share) to the Chinese partner in the event that the deal leads to great commercial success.
A foreign company may also be able to protect itself by simply writing the TIER restrictions into the contract and valuing them properly. Alternatively, the licensor could simply accept the risk of TIER and go along with the contract as if TIER were not a factor. There are also other means of possible protection (in addition to the general “best practices” mentioned in the next section. For example, instead of licensing to a company in China, it may be possible to license to a Chinese company outside the PRC. The foreign entity could provide a written contract provision prohibiting import of the technology into China, but with the unwritten understanding that the licensor will not object to such import so long as the licensee does not attempt to exploit TIER to change the contract. While this is not exactly fair for the Chinese company, neither is TIER, and it shifts the uncertainty from the licensee to the licensor. While not a perfect solution, it does reallocate the trust issue to the Chinese side.
Another option (at least for technology involving open source licensed technology) would be to contract to terms violating TIER, and then if anything goes wrong, seek to have the Free Software Foundation sue the Chinese company for violation of the open source license. This would be risky, and would require a very close relationship with the FSF and open source community. There are other possible creative solutions involving the foreign licensor using its own Chinese-owned subsidiary as the contracting party, or insisting that the licensee be a non-Chinese entity. The problem with all of these is that they have not been tested, because TIER itself has not been effectively tested. As with most business deals, it depends on the amount of risk that is tolerable to both sides.
III. Best Practices on Joint Ventures/Technology Licensing with Chinese Companies
While there is no guarantee that any contract will not be violated, there are many things that a foreign licensor can do to maximize its chances of making itself whole in the event that the contract is breached. Courts, judges, and arbitrators in China are getting more sophisticated each day. Also, such forums are generally quite fair and effective in enforcing foreign parties’ rights in China. However, the more complex the issue, the less clear the outcome and the slower the process. Therefore, several best practices should be followed in addition to general best practices regarding technology licensing outside of China.
A. Make the contract simple: define breach and liquidated damages
Although courts in China are more sophisticated than ever, they are burdened with a huge number of cases. They also are more reticent to give injunctive relief of large damages if they are not sure they are correct in their judgment. Therefore, make it easy for them: make the contract simple. Define specifically what constitutes a breach and what the penalty should be. Liquidated damages are a must. Make it so that all the aggrieved party has to show is: (1) there is a contract, (2) the contract was breached, and (3) the parties agreed at the outset what the penalty for such a breach would be. This should lead to a very fast and effective judgment.
B. Define “Confidential Information” (“CI”) clearly and put the onus on the licensee to show that information is not Confidential Information
Courts in the US get bogged down in determining what is CI under contracts. Chinese courts have the same problem. A solution to keeping up with what falls under CI is to make every bit of information provided to the Chinese partner fall under the definition. The contract should provide that all information is assumed to be CI, unless the Chinese party objects in writing within a specific period, say two weeks from receipt. There should be a provision for determining disputes quickly, including destruction of any material or information provided to the licensor that cannot be agreed as to confidential nature. Then, the licensor should provide a regular report to the licensee listing the information that it has sent the licensor and that it has received from the licensee as not constituting CI. Such a process would allow a judge of any dispute to quickly determine what was CI and provide quick redress.
C. Choices of venue and law and right to enforce judgment in China
Although the courts and arbitrators in China can now generally be trusted, if the licensee is particularly well connected, it may make sense to dictate that the choices of law and venue be in the licensor’s jurisdiction with the right to enforce any resulting judgment or adjudication in China.
D. Get a full list of officers, executives, and principals
The licensor should obtain a notarized list of officers, executives, and principals, with photos. The guards against the possibility that licensor’s CI and IP could end up in another company headed or run by the principals of the licensee. Depending on the size of the licensee and its reputation, it is very possible for the licensee to close down, move, and start up again under a new company name. Proving that this has happened will be much easier if the licensor has a list of those holding power at the original licensee. It is probably also worthwhile to get a list of lead engineers on the project.
E. Have in-document translations of each section
The contract may be in either English or Chinese, whichever the parties prefer. It is important to have in-document translations of each section. This allows for easier negotiation and for easier adjudication. One language should be controlling (likely the language corresponding to choice of venue). It may be helpful to get a notarized official translation of each section. This is not required, but for large deals is likely worth it.
F. Lay a trap
Foreign licensors of software may want to lay a trap by including in comments to the code or elsewhere specific information linking the code to the licensor. For example, add the abbreviation for the company as a note hidden multiple times throughout the code. This way, in case the licensee ever tries to argue that the code is theirs, they will have a hard time explaining why links to the licensor are there.
IV. Top IP issues when forming a joint venture in China
A. Keep control
One key to protecting IP in any deal with a Chinese partner is to make sure that the foreign entity will control the JV. Since most foreign investors wish to maintain control over their Chinese JV entity, this issue is usually paramount. Most foreign investors strive to obtain at least 51% ownership interest in the equity JV, assuming this gives them the right to control the company. However, control over a Chinese JV actually comes from the following:
· The power to appoint and remove the JV’s Legal Representative.
· The power to appoint and remove the General Manager of the JV company. The JV agreement must make clear that the General Manager is an employee of the JV company employed at the full discretion of the Legal Representative. Note that this agreement will be enforced under Chinese law and its controlling version should therefore be in Chinese.
· Control over the company seal, or “chop.” The JV partner that controls the JV’s registered company seal has the power to make binding contracts on behalf of the JV company and to deal with the JV company’s banks and other key service providers.
B. Safeguard intellectual property the traditional way
Multinational companies still struggle to protect their intellectual property in China, and JVs are particularly vulnerable. Companies have traditionally had some success with more pragmatic, operational efforts, including the following:
C. Improved and New Intellectual Property
In the growth and development of a JV, new IP will come about, and these will be regarded as belonging to the JV. Therefore, it is also up to the JV to assign it or to apply for protection. If the foreign investor only holds a minority stake in the JV, then s/he may find themselves in a weak position regarding control over new IPRs. It is recommended to deal with these matters in the JV agreement before they become problems. *Note the prior discussion of TIER in this regard.
D. License/Royalty Fees
Licensing or royalty fees from the transfer of IP in a JV deserves close attention. In China, royalties are subject to income withholding tax and business tax. Also, in some sectors, the royalty rate may have a ceiling, such as a 0.3% royalty rate ceiling of sales revenue in the retail sector for the use of a trademark.
E. Getting the money out of China and paying taxes
Transferring money out of China has always been a challenge and is only getting harder. See, e.g., https://www.nytimes.com/2016/11/29/business/economy/china-tightens-controls-on-overseas-use-of-its-currency.html. Make sure to have a plan to transfer any revenue out of China, or keep it there, and know what taxes will be applied.
Does anyone want to meet in Chicago Saturday through Tuesday? I will be there for the IPO Annual Meeting. It would be great to connect! Email me at email@example.com!
This past week, we found out that the Intermediate People’s Court in Fujian, China issued a preliminary injunction against Micron in favor of Taiwan-based UMC and Fujian-based Jinhua. See the great article by IAM here. The injunction covers “certain Crucial and Ballistix-branded DRAM modules and solid state drives. The surprising aspect was not necessarily that an injunction was issued (this happens in over 95% of Chinese patent wins) but that this was a PRELIMINARY injunction ("PI").
Like most jurisdictions, including the US, it is difficult in China to obtain a PI. The main reason is proving infringement and that the patent holder will be irreparably harmed. Specifically, Chinese courts generally consider the following factors in determining whether to issue PIs in patent cases:
Many sources seem to assume that there was some political forces at play in the Fujian court's decision. I do not dispute that surely the plaintiffs here had the hometown advantage. However, I believe the power of this advantage is not as significant as others may assume. There is a reason that in the Eastern District of Texas was popular as a venue. Similarly, there is a reason that large companies like Google have contributed a fortune in lobbying the US government to ensure they can be sued only in Northern California or Delaware. In any case, a leading US semiconductor has been -- at least temporarily -- enjoined from making, using, selling, importing, or exporting its products.
So if there are political forces are play, what are they? Well, I predicted them here:
... and here:
To reiterate, China is very likely to use its patent enforcement system to catch up in areas of technology it feels are important. China sees its huge foreign dependence for semiconductors as a national security issue. This is entirely reasonable given that semiconductors are the brains behind every device we use these days, including surveillance, computing, and artificial intelligence.
The Chinese patent litigation play could several ways. For one, NPEs attacking foreign competitors to Chinese companies will help. A more "Jedi mind trick" play, though, is to for Chinese companies to simply attack their foreign competitors in patent litigation. When the Chinese company wins the case and gets their injunction, that's when the magic comes in. With their boot on the neck of their foreign competitor, they can name their price for settlement. This price could come in terms of money, but it could mean sharing sensitive technologies -- technologies that China cannot buy due to the US increased protectionism and the Committee on Foreign Investment in the United States (CFIUS). Because settlements are generally confidential and not reported, such forced technology transfer may fly under the US radar.
No matter how important the "home field advantage" was in the latest Micron case, it likely played some role. Fortunately for Micron, the patents covered only a portion of its products. But this is not the end -- far from it. At some point, the US may find that it would have been easier to simply approved the purchase of Micron by Tsinghua Unigroup.
Welcome to the China Patent Blog by Erick Robinson. Erick Robinson's China Patent Blog discusses China's patent system and China's surprisingly effective procedures for enforcing patents. China is leading the world in growth in many areas. Patents are among them. So come along with Erick Robinson while he provides a map to the complicated and mysterious world of patents and patent litigation in China.
Erick Robinson is an experienced American trial lawyer and U.S. patent attorney based in Beijing. He is a Partner at Dunlap, Bennett & Ludwig PLLC, where he manages patent litigation, licensing, and prosecution throughout China.
The ideas and opinions at ChinaPatentBlog.com are my own as of the time of posting, have not been vetted with my firm or its clients, and do not necessarily represent the positions of the firm, its lawyers, or any of its clients. None of these posts is intended as legal advice and if you need a lawyer, you should hire one. Nothing in this blog creates an attorney-client relationship. If you make a comment on the post, the comment will become public and beyond your control to change or remove it.